Clinical Trial

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

Study acronym: MOST for PTSD
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-24; most recent amendment 2026-04-07.
Status change: Not Yet Recruiting → Recruiting 2025-12-05
Trial Details
NCT Number NCT06956781
Lead Sponsor University of Rochester
Conditions PTSD, Trauma, Pediatric ALL
Enrollment 200 participants
Start Date 2026-03-15
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-08